FI20022048A0 - Ei-kompetetiivinen immunomääritys pienille analyyteille - Google Patents

Ei-kompetetiivinen immunomääritys pienille analyyteille

Info

Publication number
FI20022048A0
FI20022048A0 FI20022048A FI20022048A FI20022048A0 FI 20022048 A0 FI20022048 A0 FI 20022048A0 FI 20022048 A FI20022048 A FI 20022048A FI 20022048 A FI20022048 A FI 20022048A FI 20022048 A0 FI20022048 A0 FI 20022048A0
Authority
FI
Finland
Prior art keywords
analyte
small
competitive immunoassay
assays
binding partner
Prior art date
Application number
FI20022048A
Other languages
English (en)
Swedish (sv)
Inventor
Timo Pulli
Matti Hoeyhtyae
Kristiina Takkinen
Hans Soederlund
Original Assignee
Valtion Teknillinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen filed Critical Valtion Teknillinen
Priority to FI20022048A priority Critical patent/FI20022048A0/fi
Publication of FI20022048A0 publication Critical patent/FI20022048A0/fi
Priority to CA2503509A priority patent/CA2503509C/en
Priority to ES03773761T priority patent/ES2312828T3/es
Priority to MXPA05005288A priority patent/MXPA05005288A/es
Priority to BRPI0316384A priority patent/BRPI0316384B8/pt
Priority to EP03773761A priority patent/EP1579222B8/en
Priority to PCT/FI2003/000875 priority patent/WO2004046733A1/en
Priority to AT03773761T priority patent/ATE408146T1/de
Priority to US10/535,260 priority patent/US7749712B2/en
Priority to CN2003801034664A priority patent/CN1711476B/zh
Priority to EA200500643A priority patent/EA200500643A1/ru
Priority to DE60323538T priority patent/DE60323538D1/de
Priority to JP2004552756A priority patent/JP4729701B2/ja
Priority to NZ539714A priority patent/NZ539714A/en
Priority to DK03773761T priority patent/DK1579222T3/da
Priority to AU2003282143A priority patent/AU2003282143B2/en
Priority to ZA200503475A priority patent/ZA200503475B/en
Priority to NO20052849A priority patent/NO338417B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Anesthesiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Wrappers (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20022048A 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille FI20022048A0 (fi)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille
AU2003282143A AU2003282143B2 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
US10/535,260 US7749712B2 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
EA200500643A EA200500643A1 (ru) 2002-11-18 2003-11-17 Способ неконкурентного иммуноанализа для определения малых аналитов
MXPA05005288A MXPA05005288A (es) 2002-11-18 2003-11-17 Inmunoanalisis no competitivo para analitos pequenos.
BRPI0316384A BRPI0316384B8 (pt) 2002-11-18 2003-11-17 imunoensaio não competitivo para analitos pequenos
EP03773761A EP1579222B8 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
PCT/FI2003/000875 WO2004046733A1 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
AT03773761T ATE408146T1 (de) 2002-11-18 2003-11-17 Nichtkompetitiver immunassay für kleine analyten
CA2503509A CA2503509C (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
CN2003801034664A CN1711476B (zh) 2002-11-18 2003-11-17 小分析物的非竞争性免疫测定
ES03773761T ES2312828T3 (es) 2002-11-18 2003-11-17 Inmunoensayo no competitivo para analitos pequeños.
DE60323538T DE60323538D1 (de) 2002-11-18 2003-11-17 Nichtkompetitiver immunassay für kleine analyten
JP2004552756A JP4729701B2 (ja) 2002-11-18 2003-11-17 小さな分析物のための非競合的な免疫アッセイ法
NZ539714A NZ539714A (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
DK03773761T DK1579222T3 (da) 2002-11-18 2003-11-17 Ikke-kompetitivt immunassay til små analytter
ZA200503475A ZA200503475B (en) 2002-11-18 2005-04-29 Non-competetive immunoassay for small analytes
NO20052849A NO338417B1 (no) 2002-11-18 2005-06-13 Ikke-kompetitiv immunoassay for små analytter.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille

Publications (1)

Publication Number Publication Date
FI20022048A0 true FI20022048A0 (fi) 2002-11-18

Family

ID=8564953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille

Country Status (17)

Country Link
US (1) US7749712B2 (fi)
EP (1) EP1579222B8 (fi)
JP (1) JP4729701B2 (fi)
CN (1) CN1711476B (fi)
AT (1) ATE408146T1 (fi)
BR (1) BRPI0316384B8 (fi)
CA (1) CA2503509C (fi)
DE (1) DE60323538D1 (fi)
DK (1) DK1579222T3 (fi)
EA (1) EA200500643A1 (fi)
ES (1) ES2312828T3 (fi)
FI (1) FI20022048A0 (fi)
MX (1) MXPA05005288A (fi)
NO (1) NO338417B1 (fi)
NZ (1) NZ539714A (fi)
WO (1) WO2004046733A1 (fi)
ZA (1) ZA200503475B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109067A1 (en) 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
JP2007040834A (ja) * 2005-08-03 2007-02-15 Japan Science & Technology Agency 免疫測定用試薬
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
GB0707870D0 (en) * 2007-04-23 2007-05-30 Selected Antibodies Ltd Assay Devices and Methods and Components for use Therein
EP2223122B1 (en) * 2007-12-18 2011-08-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Endogenous morphine or a naturally occuring metabolite thereof as a marker for sepsis
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
ES2443065T3 (es) * 2008-04-02 2014-02-17 Vivacta Limited Un método para detectar una sustancia química
US8093018B2 (en) 2008-05-20 2012-01-10 Otsuka Pharmaceutical Co., Ltd. Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
FI20085579A0 (fi) * 2008-06-12 2008-06-12 Valtion Teknillinen Kannabiskäytön toteaminen
DE102008049601A1 (de) * 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
MX2011003927A (es) 2009-07-21 2011-07-20 Sekisui Medical Co Ltd Metodo de medicion de insulina.
WO2011053783A2 (en) * 2009-10-30 2011-05-05 Merck Sharp & Dohme Corp. Ax213 and ax132 pcsk9 antagonists and variants
CA2780845C (en) * 2009-11-19 2014-12-30 Proteinexpress Co., Ltd. Fluoroimmunoassay method
US8883978B2 (en) 2010-05-11 2014-11-11 Institute For Cancer Research Antibodies to tumor endothelial marker 7R
US9599608B2 (en) * 2011-09-21 2017-03-21 Fujirebio Inc. Antibody against affinity complex
AU2012325697B2 (en) * 2011-10-21 2015-11-26 Decimadx, Llc Point-of care immunoassay for quantitative small analyte detection
EP2637021A1 (de) 2012-03-06 2013-09-11 Securetec Detektions-Systeme AG Verfahren und Vorrichtung zum Nachweis von Analyten
US9804161B1 (en) 2012-05-14 2017-10-31 Lawrence Livermore National Security, Llc Detector and related, devices, methods and systems
EP2722669A1 (de) 2012-10-22 2014-04-23 Securetec Detektions-Systeme AG Verfahren und Vorrichtung zum Nachweis von illegalen Drogen
JP6673895B2 (ja) 2014-03-21 2020-03-25 エスティー アンド ティー インターナショナル，インコーポレイティド アサ属抽出方法及び組成物
FI126746B (fi) 2014-04-07 2017-05-15 Teknologian Tutkimuskeskus Vtt Oy Vasta-aine HT-2 toksiini-HT-2 toksiini vasta-ainekompleksia vastaan
WO2017053567A1 (en) * 2015-09-22 2017-03-30 Delta Tm Technologies Designing customized protein-specific buffer systems
CA3002903A1 (en) 2015-10-23 2017-04-27 Fred Hutchinson Cancer Research Center Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
CN108779169B (zh) * 2015-12-21 2022-06-07 图尔库大学 针对包含蓝细菌环肽肝毒素的免疫复合物的抗体
AU2017209523A1 (en) * 2016-01-22 2018-08-09 Affimedix, Inc. Device for detection of vitamin D metabolites
AU2017301763B2 (en) * 2016-07-29 2023-07-06 Diazyme Laboratories, Inc. Methods and compositions for assaying vitamin D
IL294218A (en) 2019-12-27 2022-08-01 Chiome Bioscience Inc Antibody against cdcp1
CN116963779A (zh) 2020-09-02 2023-10-27 国立大学法人东京大学 癌症免疫微环境的调节物质及其预防、诊断或治疗
CA3239740A1 (en) * 2021-12-03 2023-06-08 Tim C. LEUTKENS High selective cd229 antigen binding domains and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US5223441A (en) 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
EP0759976A4 (en) 1994-03-30 2001-02-07 Igen Int Inc THE INSULATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGENTECHNOLOGY
JP3025633B2 (ja) 1995-12-05 2000-03-27 株式会社蛋白工学研究所 グルタチオン結合活性を有するポリペプチド及びその製造方法
JP4228095B2 (ja) * 1999-12-17 2009-02-25 東ソー株式会社 免疫測定方法および免疫測定試薬
CN1136450C (zh) * 2000-11-03 2004-01-28 厦门大学 具有荧光共振能量转移特征的成对蛋白及其用途

Also Published As

Publication number Publication date
JP2006506634A (ja) 2006-02-23
US7749712B2 (en) 2010-07-06
EP1579222B1 (en) 2008-09-10
ES2312828T3 (es) 2009-03-01
NZ539714A (en) 2007-03-30
BRPI0316384B1 (pt) 2016-07-05
NO338417B1 (no) 2016-08-15
BRPI0316384B8 (pt) 2021-07-27
AU2003282143A1 (en) 2004-06-15
CN1711476B (zh) 2010-09-08
WO2004046733A1 (en) 2004-06-03
CN1711476A (zh) 2005-12-21
ATE408146T1 (de) 2008-09-15
BR0316384A (pt) 2005-10-04
MXPA05005288A (es) 2005-08-16
CA2503509C (en) 2013-02-05
EP1579222A1 (en) 2005-09-28
NO20052849L (no) 2005-06-13
CA2503509A1 (en) 2004-06-03
US20060246506A1 (en) 2006-11-02
JP4729701B2 (ja) 2011-07-20
DE60323538D1 (de) 2008-10-23
ZA200503475B (en) 2006-07-26
DK1579222T3 (da) 2008-11-17
EA200500643A1 (ru) 2005-12-29
EP1579222B8 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
NO20052849L (no) Ikke-kompetitiv immunoassay for sma analytter.
WO2002090983A3 (de) Quantitaver einschritt immuntest in lyophilisierter form
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
WO2005026689A3 (en) Immunoassay device with immuno-reference electrode
EP2434286A3 (en) Immunoassay reagents and methods of use thereof
WO2007040559A3 (en) Electrochemiluminescent assay
DE602004001533D1 (de) Immunotestverfahren für Herz-Troponin I
DE502004011867D1 (de) Analytischer Sandwichtest zur Bestimmung von NT-proBNP
ATE447712T1 (de) Immunoassay mit doppelter standardkurve
ATE374944T1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
WO2007054714A3 (en) Agglutination assay
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
NO20052553D0 (no) Cobalaminanalyse.
NO20052870D0 (no) Immunoanalysemetode og sett for anvendelse derav
WO2006020263A3 (en) Cytoxan antibodies and immunoassay
WO2001063285A3 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
ATE108907T1 (de) Bestimmungsverfahren, seine verwendung und komponenten.
WO2006138694A3 (en) Rabbit monoclonal antibody against id1 protein
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
ATE336513T1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen
ATE437362T1 (de) Ig-assay